Normal pregnancy: Mechanisms underlying the paradox of a ouabain-resistant state with elevated endogenous ouabain, suppressed arterial sodium calcium exchange, and low blood pressure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 6, 2012, Pages

  Jacobs, Brandiese E ^a   Liu, Yong ^a   Pulina, Maria V ^a   Golovina, Vera A ^a   Hamlyn, John M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac glycosides; Hypertension; Mass spectrometry; Preeclampsia; Sodium pump; Vasculature

Indexed keywords

CALCIUM; NCX1.3 PROTEIN; OUABAIN; PROTEIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; KIDNEY MASS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MESENTERIC ARTERY; NONHUMAN; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; SODIUM CALCIUM EXCHANGE; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; VASCULAR RESISTANCE;

ADRENAL GLANDS; ANIMALS; ARTERIES; BLOOD PRESSURE; CALCIUM; CARDENOLIDES; CARDIOTONIC AGENTS; CHROMATOGRAPHY, LIQUID; DOWN-REGULATION; DRUG RESISTANCE; FEMALE; FETAL GROWTH RETARDATION; HOMEOSTASIS; INFUSIONS, SUBCUTANEOUS; MASS SPECTROMETRY; OUABAIN; PEPTIDES, CYCLIC; PLACENTA; PREGNANCY; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; SODIUM-CALCIUM EXCHANGER; TIME FACTORS; TRPC CATION CHANNELS; UP-REGULATION;

EID: 84863290583     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00532.2011     Document Type: Article

References (58)

1. Agunanne E, Horvat D, Harrison R, Uddin MN, Jones R, Kuehl TJ, Ghanem DA, Berghman LR, Lai X, Li J, Romo D, Puschett JB. Marinobufagenin levels in preeclamptic patients: a preliminary report. Am J Perinatol 28: 509-514, 2011.
2. Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG, Bagrov AY. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol 52: 19-23, 2006.
3. Baylis C. The mechanism of the increase in glomerular filtration rate in the twelve-day pregnant rat. J Physiol 305: 405-414, 1980.
4. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol Cell Physiol 232: C165-C173, 1977.
5. Brooks VL, Dampney RA, Heesch CM. Pregnancy and the endocrine regulation of the baroreceptor reflex. Am J Physiol Regul Integr Comp Physiol 299: R439-R451, 2010.
6. Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 55: 574-581, 2000.
7. 2+ entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. Am J Physiol Regul Integr Comp Physiol 276: R530-R538, 1999.
8. Davidge ST, McLaughlin MK. Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. Am J Obstet Gynecol 167: 1691-1698, 1992.
9. Delva P, Capra C, Degan M, Minuz P, Covi G, Milan L, Steele A, Lechi A. High plasma levels of a ouabain-like factor in normal pregnancy and in preeclampsia. Eur J Clin Invest 19: 95-100, 1989.
10. Dostanic-Larson I, Van Huysse JW, Lorenz JN, Lingrel JB. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc Natl Acad Sci USA 102: 15845-15850, 2005.
11. 2-isoform of Na-K-ATPase mediates ouabain-induced hypertension in mice and increased vascular contractility in vitro. Am J Physiol Heart Circ Physiol 288: H477-H485, 2005.
12. Douglas BH. The rat as a model for preeclampsia. Perspect Nephrol Hypertens 5: 411-419, 1976.
13. Duvekot JJ, Peeters LL. Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv 49: 830-839, 1994.
14. Fedorova OV, Bagrov AY. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms. Am J Hypertens 10: 929-935, 1997.
15. Fedorova OV, Kolodkin NI, Agalakova NI, Namikas AR, Bzhelyansky A, St-Louis J, Lakatta EG, Bagrov AY. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 23: 835-842, 2005.
16. Fedorova OV, Simbirtsev AS, Kolodkin NI, Kotov AY, Agalakova NI, Kashkin VA, Tapilskaya NI, Bzhelyansky A, Reznik VA, Frolova EV, Nikitina ER, Budny GV, Longo DL, Lakatta EG, Bagrov AY. Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension. J Hypertens 26: 2414-2425, 2008.
17. Ferrari P, Torielli L, Ferrandi M, Padoani G, Duzzi L, Florio M, Conti F, Melloni P, Vesci L, Corsico N, Bianchi G. PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. J Pharmacol Exp Ther 285: 83-94, 1998.
18. Gant NF, Whalley PJ, Everett RB, Worley RJ, MacDonald PC. Control of vascular reactivity in pregnancy. Am J Kidney Dis 9: 303-307, 1987.
19. Ganzevoort W, Rep A, Bonsel GJ, de Vries JIP, Wolf H. Plasma volume and blood pressure regulation in hypertensive pregnancy. J Hypertens 22: 1235-1242, 2004.
20. Graves SW, Williams GH. An endogenous ouabain-like factor associated with hypertensive pregnant women. J Clin Endocrinol Metab 59: 1070-1074, 1984.
21. Gregoire I, Roth D, Siegenthaler G, Fievet P, el Esper N, Favre H, Fournier A. A ouabain-displacing factor in normal pregnancy, pregnancyinduced hypertension and pre-eclampsia. Clin Sci (Lond) 74: 307-310, 1988.
22. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA 88: 6259-6263, 1991.
23. Hilton PJ, White RW, Lord GA, Garner GV, Gordon DB, Hilton MJ, Forni LG, McKinnon W, Ismail FM, Keenan M, Jones K, Morden WE. An inhibitor of the sodium pump obtained from human placenta. Lancet 348: 303-305, 1996.
24. Horvat D, Severson J, Uddin MN, Mitchell B, Puschett JB. Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy 29: 1-9, 2010.
25. Ianosi-Irimie M, Vu HV, Whitbred JM, Pridjian CA, Nadig JD, Williams MY, Wrenn DC, Pridjian G, Puschett JB. A rat model of preeclampsia. Clin Exp Hypertens 27: 605-617, 2005.
26. 2+ exchange (NCX1.3) inhibition by SEA0400. J Biol Chem 279: 7544-7553, 2004.
27. 2+ exchanger type-1 in vascular smooth muscle. Nat Med 10: 1193-1199, 2004.
28. Kahsai AW, Xiao K, Rajaopal S, Ahn S, Sun J, Oas TG, Lefkowitz RJ. Multiple ligand-specific conformations of the β2-adrenergic receptor. Nat Chem Biol 7: 692-700, 2011.
29. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283: R29-R45, 2002.
30. Kimura K, Manunta P, Hamilton BP, Hamlyn JM. Different effects of in vivo ouabain and digoxin on renal artery function and blood pressure in the rat. Hypertens Res 23, Suppl: S67-76, 2000.
31. Kurashina T, Kirchner KA, Granger JP, Patel AR. Chronic sodiumpotassium-ATPase inhibition with ouabain impairs renal haemodynamics and pressure natriuresis in the rat. Clin Sci (Lond) 91: 497-502, 1996.
32. LaMarca BD, Gilbert J, Granger JP. Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia. Hypertension 51: 982-988, 2008.
33. Li J, Khodus GR, Kruusmägi M, Kamali-Zare P, Liu XL, Eklöf AC, Zelenin S, Brismar H, Aperia A. Ouabain protects against adverse developmental programming of the kidney. Nat Commun 1: 1-7, 2010.
34. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA, Bagrov AY. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 17: 1179-1187, 1999.
35. Losonczy G, Brown G, Venuto RC. Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. Am J Med Sci 303: 233-240, 1992.
36. Manunta P, Hamilton J, Rogowski AC, Hamilton BP, Hamlyn JM. Chronic hypertension induced by ouabain but not digoxin in the rat: antihypertensive effect of digoxin and digitoxin. Hypertens Res 23, Suppl: S77-85, 2000.
37. Manunta P, Rogowski AC, Hamilton BP, Hamlyn JM. Ouabaininduced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens 12: 549-560, 1994.
38. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M, Hamlyn JM, Bianchi G. Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension 34: 450-456, 1999.
39. Nathan L, Cuevas J, Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 114: 955-960, 1995.
40. Paller MS. Decreased pressor responsiveness in pregnancy: studies in experimental animals. Am J Kidney Dis 9: 308-311, 1987.
41. Phippard AF, Horvath JS, Glynn EM, Garner MG, Fletcher PJ, Duggin GG, Tiller DJ. Circulatory adaptation to pregnancy-serial studies of haemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas). J Hypertens 4: 773-779, 1986.
42. Pierdomenico SD, Bucci A, Manunta P, Rivera R, Ferrandi M, Hamlyn JM, Lapenna D, Cuccurullo F, Mezzetti A. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension. Am J Hypertens 14: 44-50, 2001.
43. Poston L, Morris JF, Wolfe CD, Hilton PJ. Serum digoxin-like substances in pregnancy-induced hypertension. Clin Sci (Lond) 77: 189-194, 1989.
44. 2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 298: H263-H274, 2010.
45. Schoner W, Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides and their mechanisms of action. Am J Cardiovasc Drugs 7: 173-189, 2007.
46. Schrier RW, Briner VA. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol 77: 632-639, 1991.
47. Uddin MN, Horvat D, Demorrow S, Agunanne E, Puschett JB. Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia. Biochim Biophys Acta 1812: 49-58, 2011.
48. Vakkuri O, Arnason SS, Pouta A, Vuolteenaho O, Leppaluoto J. Radioimmunoassay of plasma ouabain in healthy and pregnant individuals. J Endocrinol 165: 669-677, 2000.
49. Vu H, Ianosi-Irimie M, Danchuk S, Rabon E, Nogawa T, Kamano Y, Pettit GR, Wiese T, Puschett JB. Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp Biol Med (Maywood) 231: 215-220, 2006.
50. Vu HV, Ianosi-Irimie MR, Pridjian CA, Whitbred JM, Durst JM, Bagrov AY, Fedorova OV, Pridjian G, Puschett JB. Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 25: 520-528, 2005.
51. Ward SC, Hamilton BP, Hamlyn JM. Novel receptors for ouabain: studies in adrenocortical cells and membranes. Hypertension 39: 536-542, 2002.
52. Xiao D, Buchholz JN, Zhang L. Pregnancy attenuates uterine artery pressure-dependent vascular tone: role of PKC/ERK pathway. Am J Physiol Heart Circ Physiol 290: H2337-H2343, 2006.
53. 2+ sensitivity in permeabilized uterine arteries: effect of pregnancy. Am J Physiol Heart Circ Physiol 291: H413-H420, 2006.
54. +-ATPase as a signal transducer. Eur J Biochem 269: 2434-2439, 2002.
55. Yuan C, Manunta P, Chen S, Hamlyn JM, Haddy FJ, Pamnani MB. Role of ouabain-like factors in hypertension: effects of ouabain and certain endogenous ouabain-like factors in hypertension. J Cardiovasc Pharmacol 22, Suppl 2: S10-12, 1993.
56. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, Haddy FJ, Pamnani MB. Long-term ouabain administration produces hypertension in rats. Hypertension 22: 178-187, 1993.
57. Zhang J, Lee MY, Cavalli M, Chen L, Berra-Romani R, Balke CW, Bianchi G, Ferrari P, Hamlyn JM, Iwamoto T, Lingrel JB, Matteson DR, Wier WG, Blaustein MP. Sodium pump alpha2 subunits control myogenic tone and blood pressure in mice. J Physiol 569: 243-256, 2005.
58. 2+ signaling pathway. Hypertension 56: e57, 2010.